How to Get Filspari (Sparsentan) Covered by Humana in California: Complete Forms, Appeals, and REMS Guide
Answer Box: Getting Filspari Covered by Humana in California
Humana requires prior authorization for Filspari (sparsentan) with mandatory REMS enrollment and quarterly liver monitoring. Submit via Humana provider portal or fax to 877-486-2621 with biopsy-confirmed IgA nephropathy, failed ACE/ARB therapy, and baseline labs. If denied, file internal appeal within 65 days, then California's Independent Medical Review (IMR) within 6 months—which overturns 55-69% of Humana medical necessity denials.
First step today: Verify your plan's formulary status at 1-800-486-2621 and begin REMS enrollment at filsparirems.com.
Table of Contents
- Start Here: Verify Your Humana Plan
- Required Forms and Documentation
- REMS Enrollment Process
- Submission Portals and Methods
- Specialty Pharmacy Requirements
- Appeals Process for California
- Support Resources and Contacts
- When to Contact California Regulators
Start Here: Verify Your Humana Plan
Before starting your Filspari prior authorization, confirm these basics with Humana Customer Service at 1-800-486-2621:
- Is Filspari on your plan's formulary?
- What's your specialty drug deductible and copay tier?
- Do you need CenterWell Specialty Pharmacy specifically?
- Are you enrolled in Medicare Advantage or commercial coverage?
Tip: Have your Humana member ID ready and ask for the current prior authorization form version—policies update regularly.
Coverage at a Glance
| Requirement | Details | Where to Find |
|---|---|---|
| Prior Authorization | Required for all Humana plans | Humana PA Lists |
| Formulary Status | Varies by plan—verify first | Call 1-800-486-2621 |
| Specialty Pharmacy | CenterWell required | CenterWell Info |
| REMS Enrollment | All parties must enroll | FilspariREMS.com |
| Appeal Deadline | 65 days from denial | Humana Appeals |
Required Forms and Documentation
Core Documents Needed
- Request for Medicare Prescription Drug Coverage Determination (available in English/Spanish)
- Medical necessity letter from nephrologist
- Kidney biopsy report confirming primary IgA nephropathy
- Laboratory results (within 3 months):
- UPCR ≥0.5 g/g (some plans require ≥1.0 g/g)
- eGFR ≥30 mL/min/1.73m²
- Baseline LFTs (ALT, AST, bilirubin)
- Prior therapy documentation showing ≥12 weeks of maximum-tolerated ACE inhibitor or ARB
- REMS enrollment confirmations for prescriber, patient, and pharmacy
Medical Necessity Letter Checklist
Your nephrologist's letter should include:
- Diagnosis: Biopsy-confirmed primary IgA nephropathy with ICD-10 code
- Disease progression risk: Current UPCR levels and eGFR trends
- Prior treatments: Specific ACE/ARB tried, doses, duration, and outcomes
- Clinical rationale: Why Filspari is medically necessary now
- Monitoring plan: Commitment to quarterly LFTs and proteinuria tracking
- Treatment goals: Expected reduction in proteinuria
REMS Enrollment Process
All three parties must enroll before dispensing: prescriber, patient, and pharmacy.
Step-by-Step REMS Enrollment
- Prescriber enrolls first at filsparirems.com
- Certifies understanding of hepatotoxicity monitoring
- Commits to baseline, monthly (12 months), then quarterly LFTs
- Patient enrolls next using enrollment form
- Reviews liver toxicity risks and monitoring requirements
- Provides consent for treatment
- CenterWell Specialty Pharmacy completes enrollment
- Coordinates with REMS program for dispensing authorization
Note: Don't start Filspari if ALT/AST levels are >3x upper limit of normal. Include baseline LFT results in your PA submission.
Support: Call Travere TotalCare at 1-833-345-7727 for REMS enrollment assistance.
Submission Portals and Methods
Preferred Submission Methods
| Method | Contact | Timeline | Notes |
|---|---|---|---|
| Provider Portal | provider.humana.com | 7 days standard | Best for tracking status |
| Fax | 877-486-2621 | 7 days standard | Include reference number |
| Phone | 866-488-5995 (providers) | 72 hours expedited | For urgent cases |
| Member Phone | 800-555-2546 | Varies | Patient-initiated requests |
What to Include in Submission
- Completed PA form with all required signatures
- All supporting clinical documentation
- REMS enrollment confirmations
- Clear cover sheet with member ID and drug name
- Reference number for tracking (if resubmitting)
Tip: Use the provider portal when possible—it provides real-time status updates and confirmation of document receipt.
Specialty Pharmacy Requirements
Humana requires Filspari to be dispensed through CenterWell Specialty Pharmacy. Here's how the process works:
Enrollment and Transfer Steps
- Verify network access with CenterWell directly
- Complete REMS enrollment for the pharmacy
- Submit PA through Humana with all required documentation
- Coordinate delivery once approved (up to 90-day supplies)
- Set up monitoring for quarterly LFTs and clinical support
New members can get a one-time 30-day retail supply during the first 90 days while PA processes, then all subsequent fills must go through CenterWell.
Transfer support: Contact CenterWell through the Humana provider portal for patient-specific coordination.
Appeals Process for California
If your initial PA is denied, California offers strong appeal rights through a two-level process.
Level 1: Internal Appeal with Humana
Deadline: 65 days from denial notice
Timeline: 30 days for pre-service decisions, 60 days for payment disputes
How to file:
- Online: Through your Humana member account
- Phone: Number on your ID card or 800-867-6601 for expedited
- Mail/Fax: Use forms from humana.com/member/documents-and-forms
Include with appeal:
- Original denial letter
- Updated medical necessity letter addressing specific denial reasons
- Additional clinical evidence or lab results
- Peer-reviewed studies supporting Filspari use in IgA nephropathy
Level 2: California Independent Medical Review (IMR)
When to use: After Humana upholds the denial
Deadline: 6 months from Humana's final denial
Success rate: 55-69% of medical necessity denials overturned for Humana
How to file:
- Online: HealthHelp.ca.gov
- Phone: DMHC Help Center at 1-888-466-2219
- Timeline: 45 days standard, 7 days expedited
Cost: Free to patients, and the decision is binding on Humana.
Common Denial Reasons & Solutions
| Denial Reason | How to Fix |
|---|---|
| Missing REMS enrollment | Submit enrollment confirmations from all parties |
| Insufficient prior therapy | Document specific ACE/ARB trials with doses and outcomes |
| Lab values don't meet criteria | Provide recent UPCR and eGFR within required ranges |
| Not prescribed by nephrologist | Ensure specialist involvement and co-signature |
| Missing liver function tests | Include baseline ALT, AST, and bilirubin results |
Support Resources and Contacts
Patient and Provider Support
- Humana Customer Service: 1-800-486-2621 (members)
- Provider Services: 866-488-5995
- CenterWell Specialty: Access through provider portal
- Travere TotalCare: 1-833-345-7727 (REMS and coverage support)
- Filspari HCP Resources: filsparihcp.com
Financial Assistance Options
- Manufacturer copay support through Travere TotalCare
- Patient assistance programs for qualifying low-income patients
- CenterWell financial counseling for specialty drug costs
From our advocates: "We've seen the strongest approvals when the nephrologist's letter specifically addresses the plan's denial reason—if they said 'insufficient prior therapy,' include exact drug names, doses, and duration of each ACE inhibitor or ARB tried. Don't just say 'failed prior treatments.'"
When to Contact California Regulators
California has some of the strongest patient protection laws in the country. Contact regulators if:
- Humana doesn't respond to appeals within required timelines
- You need help filing an IMR
- The plan isn't following California insurance laws
California Department of Managed Health Care (DMHC)
- Help Center: 1-888-466-2219
- Website: dmhc.ca.gov
- Online IMR filing: HealthHelp.ca.gov
- Jurisdiction: Most HMOs and managed care plans (check if your Humana plan is DMHC-regulated)
California Department of Insurance (CDI)
- Consumer Hotline: 800-927-4357
- Jurisdiction: Some PPO and indemnity plans
Counterforce Health helps patients and clinicians turn insurance denials into targeted, evidence-backed appeals. Our platform ingests denial letters and plan policies to draft point-by-point rebuttals with the right clinical evidence and procedural requirements for each payer's specific workflows.
Frequently Asked Questions
How long does Humana prior authorization take for Filspari in California?
Standard timeline is 7 days, with expedited review in 72 hours for urgent cases. Submit through the provider portal for fastest processing.
What if Filspari isn't on my Humana formulary?
Request a formulary exception with your PA submission. Include medical necessity documentation showing why formulary alternatives aren't appropriate.
Can I get an expedited appeal in California?
Yes—call 800-867-6601 if waiting could jeopardize your health. For IMR, your doctor must document that delays could cause serious harm.
Does California's step therapy law apply to Filspari?
California allows step therapy overrides when the required drug is contraindicated or has caused adverse effects. Document prior ACE/ARB failures clearly.
What's the success rate for Humana appeals in California?
Internal appeals vary, but California's IMR process overturns 55-69% of Humana medical necessity denials. Having complete clinical documentation significantly improves odds.
Sources & Further Reading
- Humana Prior Authorization Lists
- FILSPARI REMS Program
- California DMHC Help Center
- Humana Member Appeals Process
- FDA Filspari Labeling
- Travere TotalCare Support
Disclaimer: This information is for educational purposes and doesn't constitute medical or legal advice. Always consult your healthcare provider about treatment decisions and verify current insurance policies directly with Humana. Coverage policies and appeal procedures may change—check official sources for the most current information.
Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.